1. Cytotoxicity study and influence of SBA-15 surface polarity and pH on adsorption and release properties of anticancer agent pemetrexed
    Miroslav Almáši et al, 2020, Materials Science and Engineering: C CrossRef
  2. Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
    Tania Villanova et al, 2019, Proceedings of the National Academy of Sciences CrossRef
  3. Green self-assembled lactoferrin carboxymethyl cellulose nanogels for synergistic chemo/herbal breast cancer therapy
    Mai A. Atallah et al, 2022, Colloids and Surfaces B: Biointerfaces CrossRef
  4. Low-dose metronomic chemotherapy triggers oxidized mtDNA sensing inside tumor cells to potentiate CD8+T anti-tumor immunity
    Wen Qiao et al, 2023, Cancer Letters CrossRef
  5. SIRT1: An Intermediator of Key Pathways Regulating Pulmonary Diseases
    Yi-Zhu Jiang et al, 2024, Laboratory Investigation CrossRef
  6. New vistas in malignant mesothelioma: MicroRNA architecture and NRF2/MAPK signal transduction
    Manav Gandhi et al, 2020, Life Sciences CrossRef
  7. Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies
    Pierpaola Davalli et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
  8. Endogenous nucleotide as drug carrier: base-paired guanosine-5′-monophosphate:pemetrexed vesicles with enhanced anticancer capability
    Lei Xu et al, 2020, Science China Chemistry CrossRef
  9. Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer
    Ping Tian et al, 2024, Cell Biochemistry and Biophysics CrossRef
  10. Metabolic rewiring and redox alterations in malignant pleural mesothelioma
    Loredana Urso et al, 2020, British Journal of Cancer CrossRef
  11. Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin–QDs nano-hybrids: covalent coupling and phospholipid complexation approaches
    Dina G. Zayed et al, 2019, Journal of Nanobiotechnology CrossRef
  12. Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
    Derek B. Oien et al, 2018, Frontiers in Pharmacology CrossRef
  13. MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells
    Emeric Limagne et al, 2022, Cancer Cell CrossRef
  14. Butyrate induces ROS-mediated apoptosis by modulating miR-22/SIRT-1 pathway in hepatic cancer cells
    Kishor Pant et al, 2017, Redox Biology CrossRef
  15. Genetic regulation of longevity and age-associated diseases through the methionine sulfoxide reductase system
    Derek B. Oien et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  16. MDM2-dependent Sirt1 degradation is a prerequisite for Sirt6-mediated cell death in head and neck cancers
    Jung Je Park et al, 2021, Experimental & Molecular Medicine CrossRef
  17. Mitochondrial Toxicity Induced by Chemotherapeutic Drugs
    Luciana L. Ferreira et al, 2018, Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants CrossRef
  18. Study on combination therapy for lung cancer through pemetrexed‐loaded mesoporous polydopamine nanoparticles
    Jian Xu et al, 2023, Journal of Biomedical Materials Research Part A CrossRef
  19. Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function
    Lucie Hebert et al, 2017, Oncotarget CrossRef